Oligonucleoside methylphosphonates as antisense reagents
Journal Article
·
· Bio/Technology; (United States)
- Johns Hopkins Univ., Baltimore, MD (United States)
Oligonucleoside methylphosphonates contain nonionic internucleotide bonds that resist degradation by cellular nucleases and allow the oligomers to be taken up intact by mammalian cells in culture. Antisense methylphosphonate oligomers targeted against cellular or viral mRNA initiation codon or coding regions or against precursor mRNA splice sites effectively and specifically inhibit mRNA expression in cells. The efficacy of antisense methylphosphonate oligomers can be enhanced by deprivatization with functional groups that allow the oligomer to covalently cross-link with its targeted mRNA. These oligonucleotide analogs will be useful tools for studying and controlling gene expression and are also promising candidates for development as therapeutic agents.
- DOE Contract Number:
- FG02-88ER60636
- OSTI ID:
- 5217076
- Journal Information:
- Bio/Technology; (United States), Journal Name: Bio/Technology; (United States) Vol. 9:4; ISSN BTCHD; ISSN 0733-222X
- Country of Publication:
- United States
- Language:
- English
Similar Records
Interaction of psoralen-derivatized oligodeoxyribonucleoside methylphosphonates with single-stranded DNA
Targeting Cancer with Antisense Oligomers
Modulation of splicing of the preceding intron by antisense oligonucleotide complementary to intra-exon sequence deleted in dystrophin Kobe
Journal Article
·
Tue May 03 00:00:00 EDT 1988
· Biochemistry; (United States)
·
OSTI ID:6998084
Targeting Cancer with Antisense Oligomers
Technical Report
·
Tue Oct 28 00:00:00 EDT 2008
·
OSTI ID:940005
Modulation of splicing of the preceding intron by antisense oligonucleotide complementary to intra-exon sequence deleted in dystrophin Kobe
Journal Article
·
Thu Sep 01 00:00:00 EDT 1994
· American Journal of Human Genetics
·
OSTI ID:134338